MX2009005444A - Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. - Google Patents

Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Info

Publication number
MX2009005444A
MX2009005444A MX2009005444A MX2009005444A MX2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A
Authority
MX
Mexico
Prior art keywords
steroidal
delivery system
hydrophilic drug
vinyl acetate
polymer
Prior art date
Application number
MX2009005444A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005444A publication Critical patent/MX2009005444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005444A 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. MX2009005444A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062626 WO2008062008A1 (en) 2006-11-22 2007-11-21 Delivery system for a non-steroidal non-ionized hydrophilic drug

Publications (1)

Publication Number Publication Date
MX2009005444A true MX2009005444A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Country Status (6)

Country Link
US (2) US20100203104A1 (enExample)
EP (2) EP2094270A1 (enExample)
JP (2) JP2010510287A (enExample)
CA (2) CA2670157A1 (enExample)
MX (2) MX2009005444A (enExample)
WO (2) WO2008062008A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CA2657533A1 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2670157A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for risperidone
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
JP2012504146A (ja) * 2008-09-30 2012-02-16 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． リスペリドン送達用埋め込み可能型装置およびその使用方法
EP2405967B1 (en) * 2009-03-12 2020-09-23 Delpor, Inc. Implantable device for long-term delivery of drugs
DK2547332T3 (en) 2010-03-16 2018-12-17 Titan Pharmaceuticals Inc Heterogeneous implantable drug delivery devices
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
US11690806B2 (en) * 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
AU6360896A (en) * 1995-07-04 1997-02-05 Akzo Nobel N.V. Ring-shaped devices
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
JP4959907B2 (ja) * 2001-03-27 2012-06-27 ワーナー チルコット（アイルランド）リミティド 抗菌剤投与のための膣内用ドラッグデリバリーデバイス
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
MXPA05002254A (es) * 2002-08-30 2005-06-08 Alza Corp Construccion de refuerzo multilaminar estampable y registrable.
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
ATE434433T1 (de) * 2004-03-24 2009-07-15 Organon Nv Arzneimittelabgabesystem auf basis von polyethylen-vinylacetat-copolymeren
DK1824460T3 (en) * 2004-11-10 2015-01-19 Tolmar Therapeutics Inc Stabilized polymeric delivery system
MX2009005446A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro vaginal para mirtazapina.
CA2670157A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for risperidone

Also Published As

Publication number Publication date
CA2670157A1 (en) 2008-05-29
EP2094348A1 (en) 2009-09-02
JP2010510286A (ja) 2010-04-02
MX2009005445A (es) 2009-06-02
WO2008062009A1 (en) 2008-05-29
CA2670454A1 (en) 2008-05-29
US20100104619A1 (en) 2010-04-29
EP2094270A1 (en) 2009-09-02
US20100203104A1 (en) 2010-08-12
WO2008062008A1 (en) 2008-05-29
JP2010510287A (ja) 2010-04-02

Similar Documents

Publication Publication Date Title
MX2009005444A (es) Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
JP2010510286A5 (enExample)
Almeida et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
NZ628828A (en) Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
MX2009011247A (es) Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
TW200616589A (en) Transdermal delivery of drugs based on crystal size
MX2019003443A (es) Peliculas permeables con propiedades de barrera microbiana.
SI2905014T1 (en) An intrauterine delivery system for contraception
MXPA05013138A (es) Composiciones adhesivas, articulos que incorporan las mismas y metodos de manufactura de las mismas.
WO2008153611A3 (en) Sustained delivery formulations of risperidone compounds
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
ATE459345T1 (de) Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
IL223488A (en) Injectable flow bar preparation containing buprenorphine
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
WO2009039262A3 (en) Steroid containing ophthalmic drug delivery systems
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2007131193A3 (en) Main chain acid-degradable polymers for the delivery of bioactive materials
GB2544216A (en) Anti-adherent composition
WO2007112436A3 (en) Use of polymeric materials with other substances for improved performance
WO2004112713A3 (en) Drug polymer complexes
WO2009148580A3 (en) Controlled release copolymer formulation with improved release kinetics
IL280267B2 (en) A preparation for dermal administration of an active ingredient and a dressing comprising the same
WO2006013374A3 (en) Polymeric medical devices for the control of microbial infections

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal